## Abstract A few lifestyle characteristics before cancer diagnosis have been suggested to modify the prognosis of breast cancer. Followโup information from 1,453 women with incident invasive breast cancer, diagnosed between 1991 and 1994 and interviewed within the framework of an Italian multicent
โฆ LIBER โฆ
Obesity and Breast Cancer Screening : The Influence of Race, Illness Burden, and Other Factors
โ Scribed by Christina C. Wee; Ellen P. McCarthy; Roger B. Davis; Russell S. Phillips
- Book ID
- 109091624
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 187 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0884-8734
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Effect of obesity and other lifestyle fa
โ
Luigino Dal Maso; Antonella Zucchetto; Renato Talamini; Diego Serraino; Carmen F
๐
Article
๐
2008
๐
John Wiley and Sons
๐
French
โ 115 KB
๐ 2 views
Jewish ethnicity and Black race: Contras
โ
William L. Donegan; Judy A. Tjoe
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 149 KB
๐ 1 views
The association of race/ethnicity, insur
โ
Rachel A. Freedman; Katherine S. Virgo; Yulei He; Alexandre L. Pavluck; Eric P.
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 261 KB
๐ 1 views
Can mammography screening explain the ra
โ
Beth A. Jones; Stanislav V. Kasl; Mary G. M. Curnen; Patricia H. Owens; Robert D
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 1002 KB
Time dependency of the influence of prog
โ
Masataka Yoshimoto; Goi Sakamoto; Yasuo Ohashi
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 784 KB
Prognostic factors in cancer patients may be closely related to the extent of the disease and its biological properties, the elucidation of which is expected of cancer From the
Influence of treatment with tamoxifen an
โ
Svein I. Helle; Jeff M. P. Holly; Michael Tally; Kerstin Hall; Jos Van Der Stapp
๐
Article
๐
1996
๐
John Wiley and Sons
๐
French
โ 540 KB
Plasma levels of IGF-I, IGFBP-I and IGFBP-3 were measured before and during treatment with tamoxifen up to 19+ months in 34 post-menopausal patients with advanced breast cancer. In 28 patients, pro-IGF-IIE (IGF-IIE) levels were determined and IGFBP-3 was evaluated by immunoblot in 27 patients. Tamox